Harbor Capital Advisors’s Ascendis Pharma A/S ASND Stock Holding History

Harbor Capital Advisors’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,734	Closed	-$4.85M	–	1237
2025 Q4	$4.85M	Sell	22,734 -269	-1%	-$55.6K	0.38%	41
2025 Q3	$4.57M	Sell	23,003 -55,557	-71%	-$10.4M	0.36%	43
2025 Q2	$13.6M	Sell	78,560 -7,400	-9%	-$1.21M	0.57%	31
2025 Q1	$13.4M	Buy	85,960 +1,087	+1%	+$155K	0.61%	25
2024 Q4	$11.7M	Sell	84,873 -2,429	-3%	-$319K	0.51%	49
2024 Q3	$13M	Buy	87,302 +35,102	+67%	+$4.74M	0.57%	32
2024 Q2	$7.12M	Buy	52,200 +30,194	+137%	+$4.11M	0.54%	24
2024 Q1	$3.33M	Buy	22,006 +9,921	+82%	+$1.42M	0.43%	29
2023 Q4	$1.52M	Sell	12,085 -2,050	-15%	-$204K	0.29%	92
2023 Q3	$1.32M	Buy	14,135 +2,092	+17%	+$196K	0.28%	88
2023 Q2	$1.07M	Sell	12,043 -158	-1%	-$13.8K	0.22%	118
2023 Q1	$1.31M	Sell	12,201 -1,009	-8%	-$115K	0.38%	76
2022 Q4	$1.61M	Sell	13,210 -285	-2%	-$33.1K	1.56%	21
2022 Q3	$1.39M	Sell	13,495 -1,492	-10%	-$141K	1.28%	25
2022 Q2	$1.39M	Sell	14,987 -40	-0.3%	-$3.77K	1.06%	28
2022 Q1	$1.76M	Sell	15,027 -2,189	-13%	-$254K	0.83%	37
2021 Q4	$2.32M	Buy	+17,216	New	+$2.56M	0.84%	40

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Harbor Capital Advisors's ASND Position: Q1 2026 in Review

Harbor Capital Advisors sold out of Ascendis Pharma A/S (ASND) in Q1 2026, closing a stake of 22,734 shares — an estimated $4.85M sold.

Harbor Capital Advisors first reported a position in ASND in Q4 2021 and held it in 17 quarters. The position peaked at $13.6M in Q2 2025. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

Harbor Capital Advisors reported no remaining Ascendis Pharma A/S position as of Q1 2026 after selling out during the quarter.
Harbor Capital Advisors sold 22,734 Ascendis Pharma A/S shares in Q1 2026, an estimated $4.85M.
Harbor Capital Advisors first reported a position in Ascendis Pharma A/S in Q4 2021 and held it in 17 quarters.
Harbor Capital Advisors's Ascendis Pharma A/S position peaked at $13.6M in Q2 2025.
273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.